Mark R. Hake

Mark R. Hake

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Novavax Is Worth 100% More Given Its Prospects and Value Metrics

Novavax is worth roughly 100% more. NVAX stock is worth $419 given its high efficacy, cheap price, easy storage and cheap valuation compared to Moderna.

General Electric Is Worth Almost 50% More Given an Expected Sales Revival

GE stock looks almost 50% too cheap given turnarounds in its businesses. GE stock is worth almost 50% more, or $19.54, based on its forecast FCF next year as the company's sales revive.

Carnival Stock Should Go Up By 28% With Positive Earnings Growth

Investors can buy Carnival stock cheaply at a 12 P/E. CCL stock is worth 28% more at $29.71, on 2023 estimates and historical P/E multiple.

Genius Brands Has a Shot at Making It Big If It Spends Cash Wisely

Genus Brands has a shot at making it big if it spends its cash wisely. GNUS stock depends on how profitable the studio can make its deals.

$375 Million Guidance Should Lead to Positive Free Cash Flow for Skillz

Skillz's higher 2021 guidance could lead to positive FCF in 2022. SKLZ stock is worth 36% more at $21.32 once SKLZ becomes FCF positive.